More on BIAFW

- Summary
- Chart
- Profile
- Historical

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:BIAFW)
Delayed: 0.24 --0 (-0%)
Prev. Close $0.24  
Open$0.24 
52 Wk High$ 
52 Wk Low$ 
Day High$0.24 
Day Low$0.24 
P/E N/A  
EPS$ 
Volume4,897 

Friends, Peers and Foes (?): BIAF (more...)

Oct 29, 2026 08:00 AM bioAffinity Technologies Highlights Importance of Link Between Early Lung Cancer Detection and Curative Treatment During National Lung Cancer Awareness Month
Oct 15, 2026 08:00 AM bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026
Oct 9, 2026 12:30 PM bioAffinity Technologies closes $4M stock offering on Nasdaq
Oct 9, 2026 12:30 PM WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Oct 9, 2026 11:37 AM bioAffinity Technologies closes $4 million stock offering
Oct 9, 2026 11:37 AM bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Oct 8, 2026 01:30 PM bioAffinity Technologies raises ~$4M in stock offering via WallachBeth
Oct 8, 2026 01:30 PM WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Oct 8, 2026 12:07 PM bioAffinity Technologies plans $4M stock offering on Nasdaq
Oct 8, 2026 12:07 PM bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
View All Articles

Entities mentioned with BIAFW

View All Entities